Ahmed Sobhy Abdelrahim Abdallah Darwish | Cell Biology | Research Excellence Award

Dr. Ahmed Sobhy Abdelrahim Abdallah Darwish | Cell Biology | Research Excellence Award

Zagazig University & Egyptian International Pharmaceutical Industries Company, EIPICO | Egypt

Ahmed Sobhy Abdelrahim Abdallah Darwish is a highly accomplished analytical chemist with extensive expertise in analytical methodologies and chemical research. His academic journey demonstrates a consistent commitment to scientific rigor, progressing from a strong foundation in chemistry and physics to advanced studies in analytical chemistry. He has completed a diploma in analytical chemistry with distinction, a pre-master qualification with outstanding performance, and a master’s degree in analytical chemistry. Currently pursuing a Ph.D. in the same field, his research is centered on the development, optimization, and validation of analytical techniques for pharmaceutical and industrial applications. His work emphasizes precision, reliability, and innovation in chemical analysis, including method development for complex matrices, quality control protocols, and instrumental analysis techniques. His contributions aim to enhance the accuracy and efficiency of laboratory workflows, ensuring robust and reproducible results in pharmaceutical and chemical research. Additionally, he demonstrates proficiency in data interpretation, statistical analysis, and experimental design, contributing to high-quality scientific outcomes. His ongoing research reflects a commitment to advancing analytical chemistry through both theoretical insights and practical applications, positioning him as a significant contributor to the field and a strong candidate for recognition in research excellence.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications: 

Ma, J. K., Darwish, A. S., Al Ali, A., Abdelazim, A. M., Darwish, W. S., Li, X., & Huang, X. C. (2025). An ecologically sound HPLC determination of LEVOMENOL in topical therapies using a certified reference material with green properties. Results in Chemistry, 13, 102338.

Alenezi, S. S., Gouda, A. A., El Sheikh, R., Badahdah, N. A., Alzuhiri, M. E., & others. (2025). Environmental sustainability profiles assessment of HPLC stability indicating method for quantitation of piracetam and vincamine in pharmaceutical medications. Talanta Open, 11, 100407.

Darwish, A. S., Zaki, M. S. A., Salih, A. G. K. A., Ellatif, M. A., Patel, A. A., Mallick, A. K., & others. (2025). A simple eco‐friendly stability‐indicating HPLC method for determination of NETILMICIN in bulk and ophthalmic solution. Biomedical Chromatography, 39(8), e70152.

Gouda, A. A., Elsheikh, R., Eldien, A. S., & Darwish, A. S. (2025). Development and validation of stability indicating RP-HPLC method for simultaneous determination of simvastatin and fenofibrate in bulk and dosage form. Bulletin of Faculty of Science, Zagazig University, 2025(3), 134–146.

Huang, X. C., Darwish, A. S., Darwish, W. S., Chen, R. M., & Ma, J. K. (2025). Green rapid HPLC method for testing retinol and tocopherol in ophthalmic gels. Talanta Open, 100538.

Darwish, A. S., Gouda, A. A., & Eldien, A. S. (2025). Simple validated approach to quantify valsartan and sacubitril in medications using liquid chromatography. Bulletin of Faculty of Science, Zagazig University, 2025(3), 216–229.

Darwish, W. S. D., Zaki, M. S. A., Salih, A. G. K. A., & others. (2025). Developing a sensitive, ecological, and economic HPLC method for the concurrent quantification of KOLCHICINE and KHELLIN, used in bulk and sachet pharmaceuticals. Microchemical Journal, 114716.

Ma, J. K., Chen, X. Y., Zhang, N., Darwish, A. S., Gouda, A. A., El Sheikh, R., & others. (2025). A straightforward HPLC approach to testing butylated hydroxytoluene, an antioxidant, in pure and topical anti-burn gels; evaluation of greenness, blueness, and whiteness grades. Talanta Open, 100565.

Huang, X. C., Darwish, A. S., Darwish, W. S., Zaki, M. S. A., Lin, Y. T., Liang, N. L., & Ma, J. K. (2025). Ecologically conscious profiles assessments for economic, and concurrent HPLC detection of chlordiazepoxide and clidinium bromide in bulk and tablets solid dosage form. Results in Chemistry, 1, 102739.

Junning Ma | Cell Surface Receptors | Best Research Article Award

Dr. Junning Ma | Cell Surface Receptors | Best Research Article Award

Zhejiang University | China

Dr. Junning Ma has developed a multidisciplinary portfolio spanning neurosurgery, neural engineering, biomaterials, and nanomedicine. Their work integrates neural stem cell biology, targeted drug delivery, and tumor microenvironment modulation to create innovative therapeutic strategies for brain diseases. They have conducted advanced postdoctoral and doctoral research at major institutions, contributing to National Natural Science Foundation of China (NSFC) Youth Fund projects and multiple US-funded NIH and AHA grants. Their research focuses on biomimetic nanocarriers, including cell membrane-coated nanoparticles, PLGA-based delivery systems, and fusion-membrane technologies designed for precision therapy of glioma, pituitary adenoma, and ischemic stroke.

Key projects include engineered neural stem cell membrane-coated nanoparticles for stroke targeting, biomimetic nanoplatforms for cancer immunotherapy, and tumor microenvironment–responsive delivery systems. They have also contributed to studies on neuromodulation, neurotrophic factor-based therapy, neural stem cell transplantation, and photothrombotic stroke models. Their publication record includes high-impact journals such as Materials Today Bio, Biomaterials, Nano Letters, Small, and Cell Reports Physical Science, covering topics like vascular-targeting nanoclusters, polyphenol nanoparticles, and membrane-engineered carriers.

Overall, their research advances translational nanomedicine and regenerative neuroscience, with an emphasis on targeted therapies capable of overcoming the challenges of brain tumor heterogeneity, the blood–brain barrier, and ischemic neural injury.

Profiles: Scopus | Orcid

Featured Publications: 

Ma, J., Win, Y., Xiaojian, Z., et al. (2023). Enhanced EPR effects by folliculostellate cell membrane–coated nanoparticles on invasive pituitary adenoma. Materials Today Bio.

Ma, J., Dai, L., Jianbo, Y., et al. (2023). Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology. Biomaterials.

Ma, J., Liu, F., Wendy, C., et al. (2020). Co-presentation of tumor antigens with costimulation via biomimetic nanoparticles for effective cancer immunotherapy. Nano Letters.

Ma, J., Zhang, S., Jun, L., et al. (2019). Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membranes of engineered neural stem cells. Small.

Ilaria Cossu | Immunology Cellular Interactions | Research Excellence Award

Ms. Ilaria Cossu | Immunology Cellular Interactions | Research Excellence Award

University of Sassari | Italy

Ilaria Cossu is a motivated PhD candidate in Life Sciences and Biotechnologies with a specialization in Microbiology and Immunology. Their work focuses on understanding the role of human endogenous retroviruses (HERVs) in cancer, integrating molecular biology, immunology, and virology approaches to explore how retroviral elements may influence tumorigenesis. Their doctoral project involves conducting indirect ELISA assays, maintaining and analyzing cell cultures, processing blood samples, performing RNA extraction and reverse transcription, and carrying out quantitative PCR for gene expression profiling. The researcher is actively engaged in experimental design, data analysis, scientific writing, and collaborative research activities at both national and international levels.

Prior academic training includes Master’s and Bachelor’s degrees in Biology, each completed with top distinction, and research internships in microbiology, virology, and biochemistry laboratories. These experiences provided hands-on expertise in electrophoretic methods such as cellulose acetate electrophoresis, C-PAGE, fluorescent 2-aminoacridone probe (FACE) analysis, and SDS-PAGE, contributing to a solid foundation in protein and nucleic acid characterization. Their current research aims to advance understanding of retroviral contributions to cancer biology and supports the development of innovative molecular approaches for disease investigation and potential therapeutic insights.

Profile: Scopus

Featured Publications:

Cossu, I., Ruberto, S., Filippi, E., Simula, E. R., Noli, M., Mottula, A., & others. (2025). HERV-K envelope induces a humoral response in Non-Hodgkin lymphoma patients. Current Microbiology, 82(12), 574.

Jasemi, S., Molicotti, P., Fais, M., Cossu, I., Simula, E. R., Sechi, L. A., & others. (2025). Biological mechanisms of enterotoxigenic Bacteroides fragilis toxin: Linking inflammation, colorectal cancer, and clinical implications. Toxins, 17(6), 305.

Simula, E. R., Jasemi, S., Cossu, D., Fais, M., Cossu, I., Chessa, V., & others. (2025). Human endogenous retroviruses as novel therapeutic targets in neurodegenerative disorders. Vaccines, 13(4), 415. h

Ruberto, S., Santovito, A., Caviglia, G. P., Noli, M., Cossu, D., Ribaldone, D. G., & others. (2025). Mycobacterium avium subsp. paratuberculosis and human endogenous retrovirus in Italian patients with inflammatory bowel disease and irritable bowel syndrome. Immunology.

Esmaa Bouhamida | Molecular and Cellular Biology | Cell Biology Research Award

Dr. Esmaa Bouhamida | Molecular and Cellular Biology | Cell Biology Research Award

Fondazione Ricerca Biomedica Avanzata (VIMM) | Italy

The candidate’s research centers on understanding how mitochondrial signaling, hypoxia-responsive pathways, and cell-cycle regulatory networks collectively influence cardiac regeneration and cardiovascular disease. Their work investigates how hypoxia-inducible factors, particularly HIF-1α, modulate mitochondrial function during ischemic injury, with the broader goal of identifying mechanisms that could restore or enhance the regenerative potential of adult cardiac tissue. Through advanced molecular and cellular approaches, their studies explore how metabolic rewiring, mitochondrial stress responses, and oxygen-sensing pathways govern cardiomyocyte survival, proliferation, and reprogramming.

Building on expertise in molecular biology, signal transduction, and genetics, the researcher has expanded their focus to include the interplay between mitochondrial homeostasis and protein-quality control mechanisms in muscle tissues. Their postdoctoral work examines signaling pathways that regulate proteostasis and their impact on muscle integrity under physiological and pathological conditions. This integrated approach bridges cardiac regeneration, mitochondrial dynamics, and muscle biology, enabling the identification of therapeutic targets relevant to heart failure, ischemia, and degenerative muscle disorders.

Their long-term vision is to develop interventions that combine mitochondrial modulation, gene therapy, and cellular reprogramming strategies to promote tissue repair and functional recovery in cardiovascular disease. Their contributions have been recognized through competitive scientific evaluations at international cardiovascular and stem-cell research forums.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Bouhamida, E., Vadakke-Madathil, S., Mathiyalagan, P., Ranjan, A. K., Khan, A., Sherman, M. P., & others. (2025). Single nucleus transcriptomics supports a role for CCNA2-induced human adult cardiomyocyte cytokinesis. bioRxiv.

Bouhamida, E., Vadakke-Madathil, S., Mathiyalagan, P., Ranjan, A. K., Sherman, M. P., & others. (2025). Cyclin A2 induces cytokinesis in human adult cardiomyocytes and drives reprogramming in mice. npj Regenerative Medicine, 10(1), 47.

Nestor Garcia | Cellular Stress Response | Best Academic Researcher Award

Prof. Dr. Nestor Garcia | Cellular Stress Response | Best Academic Researcher Award

CONICET | Argentina

Dr. Néstor Horacio García, MD, PhD, is a physician-scientist specializing in nephrology and vascular research with a strong focus on renal physiology, hypertension, and phosphate homeostasis. He earned his medical and doctoral degrees from the National University of Córdoba, complemented by advanced research training at the Henry Ford Hospital in the United States, where he investigated mechanisms related to hypertension and vascular regulation. His postdoctoral fellowship at the Mayo Foundation in Rochester, Minnesota, further deepened his expertise in phosphate metabolism and kidney function. Dr. García has served as a Research Clinical Associate in the Nephrology Department at Sanatorium Mayo, Córdoba, where he has acted as Principal Investigator for multiple pharmaceutical protocols and clinical studies. He has also contributed to Inspiranox Therapeutics Corporation as a medical scientist and clinical research consultant, engaging in translational and therapeutic innovation. His research explores the pathophysiology of kidney disease, the molecular regulation of blood pressure, and protective mechanisms against diabetic renal dysfunction. Recognized nationally and internationally, Dr. García has received multiple awards for excellence in basic nephrology research, including honors from the Argentine Society of Hypertension and the Latin American Society of Nephrology and Hypertension (SLANH).

Profile: Orcid

Featured Publications:

García, N. H. (2021). An intensive follow-up in subjects with cardiometabolic high-risk. Nutrition, Metabolism and Cardiovascular Diseases.

García, N. H. (2021). Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease. Stroke, 52(5), e125–e132.

García, N. H. (2020). Monosialoganglioside GM1 reduces toxicity of Ptx and increases anti-metastatic effect in a murine mammary cancer model. Scientific Reports, 10(1), 10645.

García, N. H. (2020). Ibuprofen, a traditional drug that may impact the course of COVID-19: New effective formulation in nebulizable solution. Medical Hypotheses, 144, 110079.

García, N. H. (2020). Eicosapentaenoic acid prevents salt sensitivity in diabetic rats and decreases oxidative stress. Nutrition, 79–80, 110644.

Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

Prof. Dr. Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

The Ohio State University | United States

Dr. Ann-Kathrin Eisfeld is an internationally recognized physician-scientist and Associate Professor with Tenure in the Division of Hematology at The Ohio State University, where she also serves as Director of the Clara D. Bloomfield Center for Leukemia Outcomes Research. Her research focuses on the molecular and genetic underpinnings of acute myeloid leukemia (AML), with a particular emphasis on translational applications that improve patient outcomes. Dr. Eisfeld has published extensively in high-impact journals such as Nature, Leukemia, Blood, and Cell Stem Cell, contributing significantly to our understanding of leukemia biology, clonal evolution, and treatment resistance. she has authored over 100 peer-reviewed scientific publications, with an h-index of 38, more than 6,500 citations, and has led or co-led multiple collaborative studies within national consortia such as the Alliance for Clinical Trials in Oncology. Her work has identified critical biomarkers and therapeutic targets in AML, including insights into TP53 mutations, FLT3 alterations, and resistance mechanisms to venetoclax. Recognized for her integration of clinical insight with cutting-edge genomics, Dr. Eisfeld is a leading voice in precision oncology and leukemia research, shaping the future of individualized treatment strategies through both clinical innovation and scientific discovery.

Profile: Scopus

Featured Publications:

“Highly elevated serum hepcidin in patients with acute myeloid leukemia prior to and after allogeneic hematopoietic cell transplantation: Does this protect from excessive parenchymal iron loading?”

“Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia”

“miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia”

“Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia”

“Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation”

“inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations”

“Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk Patients”

“In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline”

“A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia”

Suchit Sarin | Tissue Engineering Regeneration | Best Researcher Award

Dr. Suchit Sarin | Tissue Engineering Regeneration | Best Researcher Award

Dr. Suchit Sarin | University of Nebraska Lincoln | United States

Dr. Suchit Sarin is an accomplished materials engineering researcher with over 12 years of academic and research experience in microstructural analysis, materials characterization, and process development. With a passion for advancing materials science, he has contributed extensively through his Ph.D. work at the University of Nebraska-Lincoln, where he has excelled in the use of advanced instrumentation like SEM/FIB, TEM, STEM, and XRD. Suchit has trained over 50 users on high-precision tools and worked with cross-functional teams from academia and industry. He has authored/co-authored more than 15 peer-reviewed publications in high-impact journals and conference proceedings. His research in laser surface engineering, thin films, nanostructures, and thermal materials showcases his interdisciplinary strengths. Suchit’s commitment to scientific rigor, hands-on technical expertise, and collaborative spirit make him a strong candidate for recognition as a leading researcher in his field.

Publication Profiles: 

Google Scholar
Scopus

Education:

Suchit Sarin holds a Ph.D. in Materials Engineering from the University of Nebraska-Lincoln, where he specialized in laser-material interactions, advanced microscopy, and functional surface design. Prior to this, he earned his Master of Science by Research in Metallurgical Engineering and Materials Science from the Indian Institute of Technology Bombay. His graduate and doctoral studies have involved rigorous experimental and theoretical work, particularly in nano/micro-structuring, thermophysical properties, and magnetic materials. Throughout his academic journey, Suchit demonstrated academic excellence, technical leadership, and strong communication skills. His education provided a solid foundation in both fundamental and applied aspects of materials science, further strengthened by his exposure to interdisciplinary collaborations, hands-on equipment management, and industrial partnerships. This unique academic profile has positioned him at the forefront of innovation in functional materials and energy-efficient surface technologies.

Experience:

Suchit Sarin served as the Instrument Manager for the FEI Helios NanoLab 660 DualBeam SEM/FIB at the Nano-Engineering Research Core Facility in Lincoln, NE. He conducted over 50 training sessions and ensured operational excellence through regular maintenance and calibration. He prepared advanced samples, including electron-transparent foils, nano-slits, and nanopillars, and characterized a wide range of materials—from semiconductors to geological specimens. His collaboration extended beyond academia to industrial partners such as Li-Cor Biosciences and Monolith. His earlier academic research involved synthesis, oxidation behavior, and coatings in high-temperature materials. Suchit is proficient with TEM, STEM, XRD, DSC, and simulation tools like CALPHAD (ThermoCalc), positioning him as a multidisciplinary researcher with both technical depth and cross-functional experience. His leadership in instrumentation and collaboration makes him an integral contributor to both the research ecosystem and industry-relevant innovation.

Research Focus:

Suchit Sarin’s research focuses on surface functionalization, micro/nanostructuring, and advanced materials characterization. A central theme in his work is understanding and engineering the interaction of ultrashort laser pulses with various materials to develop structures with enhanced thermal, magnetic, and catalytic properties. He has significantly contributed to the development of self-organized nano/microstructures on metals and semiconductors using femtosecond laser processing. His research has implications in energy transfer, heat dissipation, catalysis, and spintronics. He employs advanced tools like SEM/FIB, TEM/STEM, XRD, and DSC to understand structure-property relationships at multiple length scales. Additionally, he has worked on plasma-assisted catalysis and magnetic thin films, contributing to innovations in clean energy and electronics. His multidisciplinary approach integrates experimental analysis with industrial problem-solving, offering practical solutions grounded in fundamental science. With over 15 high-impact publications, Suchit’s research stands out for both its novelty and real-world applicability.

Publications Top Notes: 

  1. Growth mechanisms of micro/nano-structures from ultrashort laser ablation on copperApplied Surface Science

  2. Graph theory to quantify femtosecond laser-processed copper surfacesSurfaces and Interfaces

  3. Laser-induced quasi-periodic surface structures for enhanced vapor chamber coolingAdvanced Functional Materials

  4. Logarithmic trends in microstructures on femtosecond-lasered siliconSPIE Proceedings

  5. Spin-wave propagation in thulium iron garnet thin filmsAdvanced Electronic Materials

  6. Plasma-assisted methanol synthesis via CO₂ hydrogenationChemSusChem

  7. Room-temperature magnetic skyrmions in CoPt thin filmsACS Nano

  8. Copper surface functionalization via femtosecond laser processingSPIE Proceedings

  9. Pool boiling enhancement using femtosecond-processed aluminumIEEE ITherm

  10.  Dual-channel boiling heat transfer on laser-processed steelIEEE ITherm

Conclusion:

In conclusion, Dr. Suchit Sarin is a highly deserving candidate for the Best Researcher Award. His exceptional contributions to the field of materials science, especially in surface functionalization, electron microscopy, and energy-related applications, make him a standout nominee. With a proven track record of impactful publications, collaborative spirit, and commitment to mentorship and instrumentation excellence, he embodies the qualities of a researcher who not only pushes the boundaries of knowledge but also fosters the growth of the scientific community. With continued development in leadership and broader dissemination, he is well-poised to become a leading figure in the global materials research landscape.

 

 

Pryanka Thakur | Dengue | Young Scientist Award

Dr. Pryanka Thakur | Dengue | Young Scientist Award

Dr. Pryanka Thakur | Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh | India

Dr. Pryanka Thakur is a dedicated virologist and Project Research Scientist-I at PGIMER, Chandigarh, working in Professor Sunil Sethi’s laboratory. She earned her Ph.D. in Virology from PGIMER under the mentorship of Professor (Dr.) Radha Kanta Ratho, Dean of PGIMER. Her research revolves around molecular pathogenesis, particularly focusing on viral diseases such as Dengue, COVID-19, Hepatitis E, and emerging zoonotic threats. With numerous high-impact publications and presentations at national and international forums, Dr. Thakur has built a commendable academic and research portfolio. Her work contributes to a deeper understanding of viral mechanisms and their public health implications. She has received accolades like the Young Scientist Award and DST-SERB travel grant, reflecting her potential as a rising star in infectious disease research. Passionate about molecular diagnostics and disease pathogenesis, Dr. Thakur’s academic rigor and commitment position her as a promising candidate for the Research for Young Scientist Award.

Publication Profile: 

Orcid

Scopus

Education:

Dr. Pryanka Thakur completed her Ph.D. in Virology at the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, from August 2018 to March 2024. Her thesis, titled “Role of inflammasome and autophagy in the pathogenesis of severity of Dengue fever,” was conducted under the supervision of Professor (Dr.) Radha Kanta Ratho, a leading authority in virology. Her doctoral work explored critical host-pathogen interactions, offering insights into mechanisms influencing disease severity. During this period, she honed her skills in molecular virology, diagnostics, and cellular biology. Her academic foundation is deeply rooted in translational and clinical virology, with particular emphasis on autophagy, inflammasomes, and immunological responses during viral infections. Through her rigorous training and extensive hands-on experience with cutting-edge lab techniques, she emerged as a well-rounded scientist with both technical expertise and conceptual depth in infectious disease research, specifically RNA viruses and M. tuberculosis.

Experience:

Dr. Pryanka Thakur currently serves as a Project Research Scientist-I in the Department of Medical Microbiology, PGIMER, Chandigarh, under the mentorship of Professor Sunil Sethi. Her research has primarily focused on virological and immunological responses to emerging and re-emerging infections. She has extensive experience in molecular biology, cell culture, diagnostics, and bioinformatics, contributing to major national and international research initiatives. During her Ph.D., she contributed significantly to studies on Dengue pathogenesis, SARS-CoV-2 evolution, and the intersection of autophagy and inflammasome activity. Her experience also includes collaboration with clinicians, epidemiologists, and diagnostic labs, showcasing her ability to work in interdisciplinary settings. Beyond lab work, she has actively participated in scientific writing, mentoring junior researchers, and presenting findings at forums like ECCMID and VIROCON. Her track record reflects a strong combination of leadership, innovation, and research integrity—making her a standout young investigator.

Awards and Honors:

Dr. Pryanka Thakur’s excellence in research has been recognized through prestigious accolades. In 2024, she was honored with the Young Scientist Award at the VIROCON 2024 conference held at DRDE, Gwalior, for her impactful Ph.D. research on Dengue virus pathogenesis. Additionally, she secured the highly competitive DST-SERB International Travel Grant to present her work at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark. These honors are a testament to the significance and quality of her research in infectious diseases. Her recognition on both national and international platforms demonstrates her rising reputation within the scientific community. These awards not only validate her current achievements but also underscore her potential for future contributions to global health challenges. Her work continues to resonate with experts in virology, public health, and molecular diagnostics—solidifying her status as a promising candidate for further research awards.

Research Focus:

Dr. Pryanka Thakur’s research is rooted in the pathogenesis, immunology, and molecular biology of emerging infectious diseases. Her Ph.D. research dissected the intricate roles of inflammasome activation and autophagy dysregulation in severe Dengue infections—paving the way for targeted therapies and better clinical outcomes. She also actively investigates RNA viruses, including SARS-CoV-2, Hepatitis E, Monkeypox, Nipah, and avian influenza, exploring their mutation patterns, immune evasion strategies, and pandemic potential. Her recent studies also delve into co-infections (e.g., Dengue and COVID-19 in pregnancy), and the reemergence of known pathogens in the post-pandemic era. Dr. Thakur maintains a special interest in molecular diagnostics, enabling early and accurate disease detection. Her contributions bridge laboratory science with clinical relevance, aiming to develop diagnostic tools and deepen our understanding of host-pathogen dynamics. This interdisciplinary approach positions her to make substantial contributions to the field of translational virology and public health microbiology.

Publications Top Notes: 

  1. Waves and variants of SARS-CoV-2: Understanding the causes and effect of the COVID-19 catastropheInfection, 2022.

  2. Viral Hepatitis E and Chronicity: A growing public health concernFrontiers in Microbiology, 2020.

  3. Monkeypox virus in humans: A concern – Trespassing global boundariesInt J Surg, 2022.

  4. Emergence of novel omicron hybrid variants: BA(x), XE, XD, XF – More than just alphabetsInt J Surg, 2022.

  5. Nipah Outbreak: Beginning of another pandemic in the era of COVID-19 and Zika?Brain Behav Immun, 2021.

  6. Evolutionary dynamics of emergent SARS-CoV-2 variants: Just within a yearImmunome Research, 2021.

  7. Avian influenza revisited: Concerns and constraintsVirusDisease, 2022.

  8. Maternal and perinatal outcome in Dengue and COVID-19 co-infected pregnanciesEur J Obstet Gynecol Reprod Biol, 2023.

  9. Post-COVID-19 era: Re-emergence of known and future (X) viral pathogensVacunas, 2024.

  10.  Paclitaxel production from endophytic Mucor circinelloides from Himalayan Taxus sp.3 Biotech, 2024.

Conclusion:

In conclusion, Dr. Pryanka Thakur is an exceptionally well-qualified candidate for the Research for Young Scientist Award. Her academic rigor, publication excellence, and strong interest in infectious disease pathogenesis make her a standout young researcher. She brings a unique blend of molecular insights and public health relevance to her work, making significant contributions to understanding emerging viral threats. With national recognition and international exposure already under her belt, she is on a clear upward trajectory in academic science. Supporting her at this stage through the Young Scientist Award would not only validate her past contributions but also empower her to lead future advancements in virology, diagnostics, and translational medical research. With minor enhancements in project independence and translational focus, Dr. Thakur is poised to become a future leader in infectious disease research, making her a deserving recipient of this award.

 

Sharmil Suganya.R | Biotechnology | Best Researcher Award

Prof. Sharmil Suganya.R | Biotechnology | Best Researcher Award

Prof. Sharmil Suganya.R, Government College of Engineering, India

Prof. R. Sharmil Suganya is a dedicated academic and researcher currently serving as Assistant Professor (Senior Scale) in the Department of Electrical and Electronics Engineering (Bio-Engineering Division) at the Government College of Engineering, Salem. With over 17 years of academic experience, she has significantly contributed to multidisciplinary fields, especially biocorrosion, eco-friendly inhibitors, and biomedical instrumentation. She began her teaching career at Bharath University and later joined GCE, Salem, where she continues to mentor students and contribute to research and innovation. Her scholarly work spans numerous national and international journals and conferences, and she has co-authored over 15 papers and earned accolades through patents and impactful publications. She is well-recognized in academia with profiles on Vidwan, ORCID, and Google Scholar. Her work is marked by a strong commitment to sustainable, application-oriented research and technological innovation.

Publication Profile: 

Google Scholar

🌟 Strengths Supporting Award:

  1. Diverse Interdisciplinary Research
    Prof. Suganya bridges Biotechnology, Biomedical Instrumentation, Environmental Chemistry, and Embedded Systems—reflecting her adaptability and wide impact across disciplines.

  2. Rich Publication Record

    • Peer-reviewed journals: >15 high-quality papers including Web of Science, UGC Care, Scopus, and SCI journals.

    • Recent impactful studies: Publications in Journal of Molecular Structure, Scientia Iranica, Bulletin of the Chemical Society of Ethiopia, etc.

    • Design Patents: UK patents for a Fluorometer and a Distillation Apparatus, showing innovation beyond academics.

  3. Applied and Sustainable Research Focus

    • Contributions to green inhibitors, corrosion prevention, eco-friendly water treatment, and energy-efficient designs show her commitment to sustainability.

    • Projects like Irrigation Monitoring Systems and Induction Motor Monitoring show a hands-on engineering application.

  4. Collaborative Spirit and Mentorship

    • Multiple co-authored works with students and peers indicate strong mentorship and team leadership.

    • Research involving simulation, design, and in vitro experiments demonstrates technical skill and guidance in both computational and experimental domains.

  5. Long-standing Service & Institutional Contribution
    Over 15 years of service in Tamil Nadu Engineering Education (including DOTE & GCE Salem) reflects dedication to academic growth and public education.

🔧 Areas for Improvement:

  1. Funding and Sponsored Projects

    • While publications and patents are notable, securing national/international research grants (e.g., DST, SERB, DBT, AICTE) would significantly enhance her research stature.

  2. International Collaboration

    • Expanding collaboration with foreign universities or research groups can elevate her global research impact and visibility.

  3. Citation Metrics & H-index

    • Although her Google Scholar profile shows productivity, citation metrics could be improved through more high-impact, open-access publications and targeted dissemination.

  4. Technology Transfer / Start-up Engagement

    • Converting patents into commercial products or licensing would further reflect translational research excellence.

🎓 Educational Background:

Prof. R. Sharmil Suganya holds a B.Tech. in Biotechnology from Bharathidasan University (2004), securing First Class with 72%. She pursued her postgraduate studies in M.Sc. Biomedical Instrumentation Science at Loyola College, Chennai (Madras University) in 2006, graduating with distinction (82%). Further enhancing her academic credentials, she earned an M.S. by Research in Faculty of Technology from Anna University through the Government College of Engineering, Salem, completing it with a successful viva voce on 24.06.2020. Her multidisciplinary academic foundation combines life sciences, engineering, and technology, enabling her to bridge research across biotechnology, biomedical engineering, and electrical systems. Her educational path reflects her strong grounding in both theory and applied research, making her a versatile contributor to both academia and industry-oriented innovation.

🧑‍🏫 Academic Experience:

Prof. Sharmil Suganya began her career in 2006 as a Lecturer at Bharath University, Chennai, gaining nearly two years of foundational teaching experience. In 2008, she was appointed as an Assistant Professor via redeployment at the Directorate of Technical Education, Chennai, serving for over six years. Since 2014, she has been a part of GCE, Salem, now totaling over 17 years of teaching experience as of 2025. Her roles have included curriculum development, research mentorship, lab design, and departmental initiatives. She has guided numerous student projects, contributed to research publications, and participated in sponsored national conferences and TEQIP-funded programs. Her long tenure and steady progression demonstrate a career built on academic rigor, professional integrity, and a passion for engineering education with a bioengineering focus.

🔬 Research Focus:

Prof. R. Sharmil Suganya’s research encompasses biocorrosion, eco-friendly corrosion inhibitors, biomedical sensors, instrumentation systems, and environmental sustainability. Her core focus lies in microbe-induced corrosion (MIC) in metals, particularly mild steel and galvanized steel, and its mitigation using green inhibitors such as Trachyspermum ammi and C. sativum. She integrates materials science, chemical kinetics, and simulation-based approaches like molecular docking and MD simulation in her investigations. Her collaborative and interdisciplinary research has resulted in impactful publications across Web of Science, Scopus, and UGC Care journals, along with patents in distillation and fluorometry technologies. She is also active in IoT-based monitoring systems and instrumentation applications in agriculture and industry, thus contributing to the smart systems domain. Her work has real-world applicability, particularly in the sustainable engineering and bioengineering sectors, making her a strong contender for the Best Researcher Award.

📚 Publications Top Notes: 

  1. 📘 Investigation on MIC of Mild Steel inhibited by Trachyspermum ammi in cooling tower water – Int’l Conf. 2019

  2. 📙 Impedance Study on MIC in Mild Steel immersed in Cooling Tower Water – ETES ’19

  3. 🧪 Adsorption of Hexavalent Chromium from aqueous solution using Ocimum Tenuiflorum stem – Asian J. Res. 2017

  4. 🔍 Investigation on MIC on Mild Steel using Trachyspermum ammi in Cooling Tower Water – JSER, 2021

  5. 🌿 Biocorrosion and inhibition by a green inhibitor on Mild Steel – IJIRSET, 2021

  6. 🚜 Irrigation Monitoring System using NodeMCU & Blynk app – IJIRSET, 2021

  7. ⚙️ Remote Condition Monitoring & Fault Alert System of Induction Motor – IJIREEICE, 2020

  8. 💡 Design of Energy Efficient Lighting Loads in EEE Block at GCE – IJIREEICE, 2020

  9. 🧫 Removal of Methylene Blue using low-cost absorbents – Desalination & Water Treatment, 2023

  10. 🧪 Biocorrosion on Mild Steel and inhibition by C. Sativum – AIMS Mol. Sci, 2024

🏁 Conclusion:

Prof. R. Sharmil Suganya is highly suitable for recognition through a Best Researcher Award. Her record reflects a balanced portfolio of:

  • Innovative interdisciplinary research

  • Student mentorship and collaboration

  • Sustainable and application-oriented work

  • Continued publication and patenting efforts

With enhanced funding pursuits and international networking, she can further scale her impact. Nevertheless, her existing contributions are outstanding in both depth and breadth, making her a strong candidate for this honor.

Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Dr. Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Dr. Maria Andriolo, ASP CALTANISSETTA, Italy

Maria Andriolo is a dedicated biomedical researcher and clinical biologist with extensive experience in neuroscience, immunology, and post-traumatic disorders. Her multidisciplinary approach has led to impactful contributions in clinical diagnostics, neurorehabilitation, and infectious disease studies. With decades of experience across leading Italian institutions, she combines clinical insight with scientific rigor. She has served in prestigious roles such as a Member of the State Examination Commission and President of Public Selection Committees. Dr. Andriolo is widely published, collaborating on pioneering studies in fields including brain trauma, sepsis diagnostics, and vaccine immunoresponse. Known for her collaborative spirit and leadership, she also contributes as a conference moderator and educator. Her body of work reflects a deep commitment to translational science that benefits patient care and public health.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Multidisciplinary Research Impact
    Dr. Andriolo’s work spans key medical research areas including:

    • Neurology (e.g., traumatic brain injury, disorders of consciousness)

    • Clinical Biochemistry (e.g., neuron-specific enolase, BDNF, CSF biomarkers)

    • Microbiology & Infectious Diseases (e.g., antimicrobial resistance, sepsis diagnostics)

    • Immunology & Vaccine Response (e.g., post-COVID vaccine serology in healthcare workers)

  2. Innovation with Real-World Impact
    Her studies focus on biomarkers for rapid diagnosis, rehabilitation outcomes, and immune responses, directly translating into improved patient care, particularly in:

    • Post-traumatic brain disorders

    • Early detection of sepsis

    • Infection control strategies

  3. Collaborative and High-Impact Publications

    • Extensive peer-reviewed articles in PubMed-indexed journals like Journal of Neurotrauma, Brain Sciences, Vaccines, and Science Reports.

    • Publications show collaborations with leading national research teams and hospitals.

  4. Scientific Leadership & Recognition

    • Appointed as President of National Selection Committees and State Examiner for Biologist Certification.

    • Served as Moderator at ECM Conferences, further demonstrating peer trust and scientific communication skills.

⚠️ Areas for Improvement:

  1. Lead Authorship and Project Ownership

    • While her publication record is strong, she is mostly listed as co-author. Clear documentation of principal investigator roles, research grants led, or independent innovation patents would further bolster her candidacy.

  2. International Presence

    • A broader international profile (e.g., global conferences, cross-border collaborative studies, citations from non-EU entities) could elevate her global impact.

  3. Recent Innovation Highlights

    • A focused submission highlighting a single groundbreaking innovation (e.g., biomarker panel for TBI prognosis or rapid sepsis tool) would align more clearly with “Best Innovation” award criteria.

🎓 Education:

While the detailed educational background isn’t listed, Maria Andriolo’s professional and scientific achievements imply a robust academic foundation in Biology, Neuroscience, and Clinical Diagnostics, likely culminating in at least a Master’s or Doctorate-level education in Biomedical Sciences. Her involvement as a State Examiner for Biologist Qualification and leader of academic committees suggests a longstanding connection with university-level institutions, particularly the University of Messina. Given her expertise and publication record, it is evident she has received specialized training in neurobiology, molecular genetics, clinical chemistry, and medical microbiology. She has actively participated in ECM-accredited medical conferences, indicating a commitment to continuing professional development. This mix of structured education and applied training positions her as a highly qualified scientific professional.

💼 Professional Experience:

Maria Andriolo holds significant academic and clinical leadership roles. She was appointed in July 2024 as a Member of the State Examination Commission for Biologists at the University of Messina, overseeing professional certifications. In June 2023, she served as President of the Examination Committee for a public selection competition for C1 research staff. She is frequently invited to act as a moderator at ECM-accredited conferences, underscoring her peer recognition in the field. Her expertise spans biomedical research, academic evaluation, and public health diagnostics. Maria’s ability to combine scientific knowledge with regulatory oversight and teaching makes her a valuable contributor to academia and public institutions. Her leadership and participation in national scientific initiatives demonstrate her commitment to innovation, clinical application, and academic excellence.

🔬 Research Focus:

Maria Andriolo’s research is anchored in neuroscience, post-traumatic disorders, biomarkers, and infectious diseases. Her work often centers on patients with disorders of consciousness following trauma, analyzing biomarkers like BDNF, neurofilaments, and amyloid-beta proteins. She is a leading contributor in understanding the neurochemical pathways associated with brain injury and rehabilitation. Maria has also co-authored influential studies on sepsis diagnostics, immune response to COVID-19 vaccines, and antimicrobial resistance. Her research combines laboratory diagnostics with clinical applications, enabling faster diagnoses and more effective treatment strategies. She is known for utilizing multidisciplinary frameworks, involving neurologists, microbiologists, and clinicians to translate science into solutions. This strong translational impact underscores her candidacy for the Best Innovation Award, as she bridges the gap between research and patient-centered innovation.

📚 Publications Top Notes:

  1. 🧠 Reduced neuron-specific enolase levels in chronic severe traumatic brain injury

  2. 🧬 Multidisciplinary approach for the rapid diagnosis of sepsis

  3. 💉 Serological analysis of humoral immune response in Sicilian HCWs post-COVID vaccination

  4. 🧠 Dissociation of CSF amyloid-beta and tau in post-traumatic consciousness disorders

  5. 💉 Staphylococcus aureus in bloodstream infections: frequency & antimicrobial resistance

  6. 🧠 Serum BDNF levels are reduced in disorders of consciousness

  7. 🧠 Six-month outcomes in traumatic consciousness disorders (hemorrhagic/non-hemorrhagic)

  8. 🧠 BDNF Val66Met polymorphism and post-traumatic vegetative state recovery

  9. 💉 Anaphylaxis to streptomycin

  10. 🧠 Prolonged CSF neurofilament light chain increase in traumatic brain patients

🏁 Conclusion:

Maria Andriolo is a highly suitable and deserving candidate for the Research for Best Innovation Award. Her research demonstrates:

  • Exceptional depth in translational neuroscience and diagnostics

  • A strong commitment to multidisciplinary collaboration

  • A clear track record of innovation that impacts both patient outcomes and healthcare protocols